How to Administer Your Second Dose of Mounjaro

What the clinical guidance actually says about your second injection

The Mounjaro SmPC, available in full on the electronic Medicines Compendium, is the authoritative source for injection technique. It confirms that tirzepatide is delivered subcutaneously (into the fatty tissue just beneath the skin) at a 90-degree angle for most people, or 45 degrees if you have very little subcutaneous tissue at that site. The KwikPen does the measuring for you: each pen contains four weekly doses at your prescribed strength, with the dose dial advancing automatically after each use.

For your second injection, the most important shift from guidance is site rotation. Injecting repeatedly into the same area can cause lipohypertrophy, a hardening of the tissue that slows absorption and blunts the medicine's effect. The abdomen (at least 5 cm from the navel), the front or outer thigh, and the upper arm are all licensed sites; moving between them week to week keeps tissue healthy. You can also vary the spot within each site, a few centimetres from where you injected before is enough.

NHS patient guidance for tirzepatide, available at nhs.uk/medicines/tirzepatide, reinforces that the pen should be removed from the fridge and allowed to reach room temperature before use, typically around 30 minutes. If you want a full walkthrough of how to administer your second dose of Mounjaro, including the correct angle and hold time, our dedicated guide takes you through it step by step.

The seven-day rule and what to do if your timing slips

The licensed schedule is once weekly. For practical purposes, that means picking one day (Tuesday morning before work, or Sunday evening before the week starts) and staying with it. Consistency matters because tirzepatide's half-life is designed around that seven-day window; drifting your injection day by a few hours either side over several weeks can create subtle fluctuations in exposure.

If you genuinely miss the window for your second dose, the SmPC and Patient Information Leaflet set out what to do, and this is precisely the kind of question to put to your prescriber rather than make a judgement call on. At our contact page you can reach our clinical team seven days a week. The one thing that is consistent across guidance: never take two doses in the same week to compensate. The prescriber-approved approach is always in the leaflet inside the box.

People who find a weekly ritual easier to remember tend to tie the injection to something fixed in their schedule. One patient's note from our clinical team: several people inject on a Friday morning, so any mild nausea settles over the weekend rather than clashing with a busy work day. It is a small detail, but across months of treatment it adds up.

Side effects to watch after your second dose, and when to act

Nausea, indigestion, constipation and loose stools are the most commonly reported effects in the SURMOUNT-1 trial data and in clinical practice. They are typically most noticeable in the early weeks and tend to ease as the body adjusts; the second dose sits in that adjustment window. Our guidance on what to expect from your 2nd dose of Mounjaro covers the adjustment period in detail, including the dietary approach most prescribers recommend of eating smaller portions, prioritising protein and fibre, and drinking plenty of water.

Two signals warrant prompt attention. First, severe stomach pain that spreads to the back, with or without vomiting: the MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. Seek urgent medical assessment rather than waiting to see how it settles. Second, signs of a serious allergic reaction, swelling of the face, lips or throat, difficulty breathing, rapid heartbeat. These are rare but require emergency care.

For those thinking about the longer cost picture of treatment, our Mounjaro pricing page explains what a private prescription through a regulated pharmacy typically covers, so nothing arrives as a surprise. Our clinical team's background and approach is outlined on our clinical lead's profile for anyone who wants to understand who reviews these prescriptions.

Preparing your pen and completing the injection

The practical sequence for your second dose is the same as the first, but worth stepping through again because small errors become habits. Take the pen from the fridge the morning of your injection day, the same morning the kettle goes on is a useful cue. Check the liquid through the viewing window: it should be clear to slightly yellow with no visible particles. If it looks cloudy or has changed colour, do not use it; contact your prescriber.

Clean the chosen site with an alcohol swab and allow it to air dry. Remove the pen cap, press the pen flat against the skin at the correct angle, and activate the dose according to the instruction in your leaflet. Hold it in place until the injection is complete, the leaflet specifies the count. Dispose of the used pen in an approved sharps container; household bins are not appropriate for used pens.

For anyone new to the treatment or considering starting, our Mounjaro information page covers the full treatment picture, and the weight-loss treatments overview sets out how it sits alongside other licensed options. If you are using a vial and bacteriostatic water rather than the KwikPen, our guide on how to mix 10mg tirzepatide with bacteriostatic water walks you through reconstitution safely, and our separate page on how to take your 2nd dose of Mounjaro covers the full injection process for that format. If a question isn't answered there, our FAQs are worth a look before getting in touch directly. And if you are ready to discuss your suitability with a clinician, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.